99% of clinical trials for Alzheimer’s disease fail to show positive results, but researchers remain optimistic that new disease-modifying treatments are on the horizon
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A one-two punch targeting reactive oxygen species and fibril for rescuing Alzheimer’s disease
Nature Communications Open Access 24 January 2024
-
Multi-omic atlas of the parahippocampal gyrus in Alzheimer’s disease
Scientific Data Open Access 08 September 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moutinho, S. The long road to a cure for Alzheimer’s disease is paved with failures. Nat Med 28, 2228–2231 (2022). https://doi.org/10.1038/s41591-022-02062-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-022-02062-0
This article is cited by
-
A one-two punch targeting reactive oxygen species and fibril for rescuing Alzheimer’s disease
Nature Communications (2024)
-
Multi-omic atlas of the parahippocampal gyrus in Alzheimer’s disease
Scientific Data (2023)